Author Guidelines

       "Noto Serif"

Case Report                                      2

Original Research                           3 "Noto Serif"

Clinical Distillation                         4"Noto Serif"

Style Elements                                 5

Permissions and Copyright          6"Noto Serif"

What to Expect After Submission       7
"Noto Serif"

Case Report

  • Word count: ~1600 words (as assigned by editorial team) + references, tables, figures.
  • Consent: Provide a statement to AJEM confirming that the patient has given their written informed consent to the author for the case report to be published. Do NOT submit the written consent to AJEM (because of privacy issues). Author should keep the written consent in their personal records, allowing the editor-in-chief to request review if necessary. If the patient is a minor, or unable to provide consent, then consent must be obtained from the patient’s parents or legal guardians.
  • Patient privacy: Authors should remove information from photographs and manuscripts that might identify a patient.
  • Manuscripts are considered for publication with the understanding that no part of their contents are under consideration for publication elsewhere; have not been published or posted elsewhere; and will not be posted or published elsewhere.

Elements

  • Summary: ~300 words describing the clinical case, treatment, key findings, and conclusions, including what the reader should learn from this case.
  • Introduction: 1-2 paragraphs describing the clinical question or issue discussed in the case report and its importance in clinical practice or public health. Provide background on what was previously known about this topic from other research (with references).
  • History: Provide a concise medical history in chronological order beginning with the primary complaint and including duration of signs/symptoms, medication history, physical examination and laboratory testing findings, comorbidities, and relevant sociodemographic information.
  • Results: Provide a timeline of treatment regimen, observations, physical examination and laboratory testing results, and follow-up.
  • Conclusion: Provide a concise summary of the findings and clinical implications. Describe what value this case provides for practicing clinicians, and suggest avenues for future research.
  • Disclosure: Provide full disclosure information. List any funding/grant information.
  • References: See section below “References.”
  • Permissions: Author must secure permission to reprint fables/figures/images previously published, and send permission information to AJEM


Original Research

  • Word count: ~2400 words (as assigned by editorial team) + references, tables, figures.
  • Manuscripts are considered for publication with the understanding that no part of their contents are under consideration for publication elsewhere; have not been published or posted elsewhere; and will not be posted or published elsewhere.

Elements

  • Abstract: (~300 words) Structured abstract to include the following sections: objective, methods, results, conclusion.
  • Introduction: 1-2 paragraphs describing the clinical question or issue and its importance in clinical practice or public health. Provide background on what was previously known about the topic from other research (with references). Discuss study rationale, goals, and hypotheses.
  • Methods: Trial design, funding, oversight, patient population and characteristics, inclusion/exclusion criteria, trial procedures, primary and secondary outcomes, statistical analysis.
  • Results: Provide primary and secondary outcome data including statistical analysis (P- values, CI, hazard ratio, etc) data when available.
    • Report CIs when possible
    • For P-values between 0.001 and 0.20, please report the value to the nearest thousandth. For P-values >0.20, please report the value to the nearest hundredth. For P-values <0.001, report as “P<0.001”
    • Standard deviation: Use “mean (SD)”
  • Conclusions: Provide an overview of study findings, highlight potential clinical implications of the findings, discuss study strengths/limitations, and suggest avenues for future research on this topic.
  • References: See section below “References.”
  • Disclosure: Provide full disclosure information. List any funding/grant information.
  • Include tables and figures.
  • Avoid opinion and personal bias.
  • Permissions: Author must secure permission to reprint fables/figures/images previously published, and send permission information to AJEM

Clinical Distillation

  • Word count: ~800 words (as assigned by editorial team) + references, tables, art.
  • Introduction: Provide a brief summary (≤300 words) of the key study findings, written in your own words. AJEM cannot publish excerpted sections of a previously published study due to copyright restrictions. 
  • The bulk of the text should include a commentary on:
    • The clinical implications of the findings
    • Strengths/limitations of the study design
    • Future research on the topic that is currently being conducted (including your own) or aspects of the topic that you hope will be studied in the future
    • In general, why is this study valuable for our readers to know about and how can they apply this information in clinical practice?
  • Please reference all background information and discussion of other studies (see “References” section).

Style Elements

Abbreviations: Spell out at first mention and put abbreviation in parentheses. Use abbreviation throughout the rest of the text. Only use abbreviation if term is used 2 or more times in the article.

  • Please use delta-9-tetrahydrocannabinol (THC) on first use; THC thereafter if 2 or more mentions
  • Please use cannabidiol (CBD) on first use; CBD thereafter if 2 or more mentions

Drug names: Generic names should be used. If brand names are needed for clarification, please put in parenthesis after the generic name:

  • cannabidiol oral solution (Epidiolex)

References

  • Authors are responsible for the accuracy and completeness of their references and for correct text citation. Number references in the order they appear in the text; do not alphabetize.
  • Convert all references imbedded with referencing software to plain text before submission
  • Format: AMA Manual of Style, 11th edition
  • Journal articles:
    • Millar SA, Stone NL, Bellman ZD, Yates AS, England TJ, O’Sullivan SE. A systematic review of cannabidiol dosing in clinical populations. Br J Clin Pharmacol. 2019;85(9):1888-1900.
    • Pauling JD, Hughes M, Pope JE. Raynaud’s phenomenon—an update on diagnosis, classification and management [E-pub ahead of print]. Clin Rheumatol. 2019. doi:10.1007/s10067-019-04745-5
  • Book:
    • Iverson C, Christiansen S, Flanagin A, et al. AMA manual of style: a guide for authors and editors. 11th ed. Oxford University Press; 2019.
  • Online source:

Title and byline

  • Include a suggested title
  • Byline should include full name, degrees, title, affiliation, town/states

Permissions and Copyright

Permissions

It is the author’s responsibility to obtain permission to reprint or adapt previously published text/tables/figures/images. Submit proof of granted permission with manuscript.

Copyright

All materials in AJEM are protected by United States copyright laws. No part may be reproduced, transmitted, displayed, published, or broadcast without prior written consent of GreenMeds Communications.

Please contact AJEM at ken@ajendomed.com to request permission to share, reprint, or adapt paper in full or in part. Republication of AJEM articles in part or in full (online or in print) should reference initial publication in AJEM.  

Credit should read as follows: “From [Publication Title, Author(s), Title of Article, Volume No., Page No. Copyright © (notice year) American Journal of Endocannabinoid Medicine. Reprinted with permission.

What to Expect After Submission

  • Manuscript will be reviewed/edited internally by the editorial team
  • Peer reviewers will evaluate the manuscript
  • Author will be sent back edited article with any requests for further information/clarification/referencing from the editors and peer reviewers
  • Author will review the final version of the article as a PDF prior to publication